Sepha's Multi-bottle Leak and Seal Tester - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Sepha's Multi-bottle Leak and Seal Tester



Untitled Document

Sepha, a Belfast, Ireland based company launched BottleScan, a multibottle integrity tester for induction-sealed pharmaceutical bottles. BottleScan uses force-decay technology to detect weak seals and defects down to 15 microns. It has a toolless design and can test up to four bottles simultaneously in a cycle of approximately 60 seconds. The system produces objective, pass-or-fail results enabling good bottles to be returned to the production line. BottleScan has the ability to run in compliance with 21 CFR Part 11, offering pharmaceutical manufacturers and packagers a solution for testing the integrity of induction-sealed bottles.

Source: Sepha

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here